Investigation of reduction process and related impurities in ezetimibe

Three novel reduction process related impurities (impurity-I-III) in ezetimibe bulk drug were synthesized, isolated, identified, and characterized using HPLC (analytical), MS, 1H, 13C, 2D NMR and IR techniques. To the best of our knowledge, these impurities were first reported in this paper.